Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-012335
Filing Date
2023-05-05
Accepted
2023-05-05 14:59:55
Documents
2
Period of Report
2023-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1531
2 EX-24 DOCUMENT attachment1.htm EX-24 1582
  Complete submission text file 0000899243-23-012335.txt   4528
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EXICURE, INC. 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address
Hwang Jiyoung (Reporting) CIK: 0001960063 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39011 | Film No.: 23893264